Epigenomic analysis sheds light on risk factors for ALS
In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.
Stay updated with breaking news from A Cure Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.
/PRNewswire/ -- The "Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
It's been a year since John Driskell Hopkins "Hop" from ZBB announced his ALS Diagnosis. He's hold a concert this week to Hop On A Cure For ALS
It's been a year since John Driskell Hopkins "Hop" from ZBB announced his ALS Diagnosis. He's hold a concert this week to Hop On A Cure For ALS
It's been a year since John Driskell Hopkins "Hop" from ZBB announced his ALS Diagnosis. He's hold a concert this week to Hop On A Cure For ALS